Biotest Aktiengesellschaft

BRSE:000325670 Voorraadrapport

Marktkapitalisatie: CHF 1.3b

Biotest Toekomstige groei

Future criteriumcontroles 0/6

Biotest's revenue and earnings are forecast to decline at 4.1% and 67.2% per annum respectively while EPS is expected to decline by 84.1% per annum.

Belangrijke informatie

-67.2%

Groei van de winst

-84.1%

Groei van de winst per aandeel

Biotechs winstgroei36.4%
Inkomstengroei-4.1%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt09 Sep 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

BRSE:000325670 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202571259N/AN/A1
12/31/2024636-4N/AN/A1
6/30/202478116486119N/A
3/31/2024783177-1023N/A
12/31/2023685127-36-3N/A
9/30/2023683119-122-93N/A
6/30/2023538-10-146-117N/A
3/31/2023517-47-127-98N/A
12/31/2022516-32-70-40N/A
9/30/2022505-69-414N/A
6/30/2022511-653049N/A
3/31/2022512-545169N/A
12/31/2021516-631634N/A
9/30/2021514-28-324N/A
6/30/2021507-33-32-5N/A
3/31/2021507-35-49-22N/A
12/31/2020484-31-44-17N/A
9/30/2020466-34-74-40N/A
6/30/2020459-24-83-49N/A
3/31/2020439-15-70-36N/A
12/31/2019419-5-68-34N/A
9/30/2019406-9-74-19N/A
6/30/2019395-3-61-6N/A
3/31/2019390-6-81-26N/A
12/31/2018400-13-105-50N/A
9/30/201840518-123-16N/A
6/30/20184096-1006N/A
3/31/20184001N/A15N/A
12/31/2017378-16N/A34N/A
9/30/2017257-48N/A8N/A
6/30/2017301-47N/A-8N/A
3/31/2017340-29N/A35N/A
12/31/20164086N/A66N/A
9/30/2016531128N/A51N/A
6/30/201652552N/A57N/A
3/31/201652636N/A44N/A
12/31/201553527N/A38N/A
9/30/2015590-88N/A62N/A
6/30/20156063N/A54N/A
3/31/201560216N/A15N/A
12/31/201458219N/A-11N/A
9/30/201454327N/A-26N/A
6/30/201452231N/A-28N/A
3/31/201450430N/A-1N/A
12/31/201350132N/A-7N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 000325670's earnings are forecast to decline over the next 3 years (-67.2% per year).

Winst versus markt: 000325670's earnings are forecast to decline over the next 3 years (-67.2% per year).

Hoge groeiwinsten: 000325670's earnings are forecast to decline over the next 3 years.

Omzet versus markt: 000325670's revenue is expected to decline over the next 3 years (-4.1% per year).

Hoge groei-inkomsten: 000325670's revenue is forecast to decline over the next 3 years (-4.1% per year).

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if 000325670's Return on Equity is forecast to be high in 3 years time

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y